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Abstract 
Emrah Yildir 
Physically and chemically modified cellulose for drug delivery 
Doctor of Philosophy in Pharmaceutical Sciences Thesis 
Pharmaceutical Sciences Laboratory, Åbo Akademi University 
 
Modern advances in pharmaceutical industry have raised the interest in 
designing, modifying and regenerating polymers which can improve the 
quality of final dosage forms. Cellulose, as the most abundant biopolymer on 
the world, has been extensively studied by scientists over decades. 
Characteristics of the natural form of cellulose can be altered by physical and 
chemical modification methods depending on the attributes needed for the 
end product. These methods aim to break the hydrogen bonds between 
cellulose chains or replace a hydroxyl group with a functional group, in order 
to obtain the desired properties.  
The aim of the present work was to investigate the pharmaceutical 
applications of cellulose beads and discs which were produced by a novel, 
environmentally friendly, physical and chemical modification technique of 
natural cellulose. First, we investigated drug entrapping and release abilities 
of novel porous cellulose beads which were formed by dissolving cellulose in 
sodium hydroxide-urea-water solvent system and then dropping the solution 
into an acidic medium. Next, the cellulose beads were chemically modified by 
oxidation and these oxidized, negatively charged beads were loaded with 
cationic drugs to study the effect of opposite charges on drug entrapment and 
release. As final step, dissolved cellulose was shaped into another geometric 
form; namely discs, by changing the properties of the precipitation medium 
to explore their possible usage in oromucosal drug delivery. 
In conclusion, the results showed that non-oxidized beads, oxidized beads 
and discs can be used as a versatile excipient for the production of different 
pharmaceutical dosage forms. However, comprehensive evaluation of the full 
potential of cellulose beads and discs need further investigation.  
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1. Introduction 
Polymeric materials have been extensively studied and utilized by the 
pharmaceutical industry. The initial use of polymers was limited to 
polystyrene vials, rubber closures, polyvinly chloride bags and simple 
gelatine capsule shells. However, advancements in polymer and 
pharmaceutical sciences led to the amalgamation of these two-scientific field. 
Nowadays, different types of novel or functionalised polymers are used in the 
design and development of novel drug-delivery systems (DDSs) [1,2]. 
 
Cellulose, the most abundant, naturally occurring biopolymer, is a 
pharmaceutically acceptable and compendial polymer for tableting and 
capsule filling purposes. Moreover, the polysaccharide can be physically 
modified to form different shapes such as fibres of different geometry, films, 
discs, or spherical particles. In addition, cellulose derivatives with specific 
properties, ranging from hydrophilic to hydrophobic, from non-charged to 
an-, cat- or poly-ionic can be obtained by chemical modification of the 
cellulose.  In the pharmaceutical industry, modified cellulose is used as an 
excipient to control and/or sustain the drug release, to coat tablets (osmotic 
and enteric coating), to increase the mucoadhesiveness of the formulation and 
to enhance the compressibility of the powder mixture. Even though there are 
many excipients derived from cellulose used in drug formulations, the 
pharmaceutical industry tries to improve manufacturing processes, decrease 
the costs and improve the performance of existing products by investigating 
and developing different modification methods to create desired cellulose-
based excipients [3,4].  
 
In the literature it has been described that cellulose microspheres, films or 
discs can be created by first dissolving the cellulose with a non-derivatizing 
or derivatizing solvent system and later dispersing or dropping the dissolved 
cellulose into a coagulation bath to form desired final shape (physical and 
chemical modification) [5,6]. Most of these procedures use derivatizing 
solvents and include various disadvantages such as using an excess of 
chemical because of the regeneration step. Recently, the utilization of 
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environmentally friendly and non-derivatizing solvent systems to dissolve 
cellulose and then  shape and/or modify the desired cellulose product have 
raised a lot of interest [7,8]. 
 
The aim of this thesis was to investigate the potential of physically and 
chemically modified cellulose for drug delivery purposes. Physical 
modification was performed by first dissolving the cellulose in an 
environmentally friendly solvent system and dropping the dissolved 
cellulose into an acidic medium to coagulate desired shapes such as beads and 
discs. Later, the chemistry of cellulose beads was changed by altering the 
functional group with an oxidation procedure. All the generated beads and 
discs were studied as potential drug carriers due to their tailorable specific 
surface area and high porosity, uniform volume, weight, shape, and ionic 
charge. 
 
In order to achieve the goal of this thesis, first, cellulose was physically 
modified by dissolving it in a water-based solvent system and then dropping 
the dissolved cellulose into an acidic medium to obtain bead like shapes. 
Freely and poorly water soluble active pharmaceutical ingredients (APIs) 
were loaded into physically modified beads and drug entrapment, release and 
distribution were studied. Then, some of these cellulose beads were oxidized 
to obtain functionalised, anionic beads by chemical modification. A cationic 
model drug was incorporated into oxidized and unoxidized beads and 
subsequently the effect of the amount of anionic groups in the cellulose beads 
on drug incorporation and release were investigated. As a final step, disc 
shaped cellulose precipitates were shaped by changing the properties of the 
acidic precipitation media and their potential for oromucosal drug delivery 
was investigated. Hardness, drug content and in vitro release profiles were 
studied and compared with a marketed product. 
                                                                                 Literature review 
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2. Literature review 
A polymer is a macromolecule formed by the repetition of small structural 
chemical units called monomers. Polymeric materials are divided into two 
groups; biopolymers (natural) and synthetic polymers (man-made). 
Biopolymers are extracted from living organisms and can be protein based 
such as collagen and albumin or polysaccharides such as cellulose, chitosan 
and starch. On the other hand, synthetic polymers are derived from 
petroleum oil and can be biodegradable such as polyesters, polyanhydrides 
and polyamides or non-biodegradable such as some cellulose derivatives (e.g. 
ethyl cellulose), silicones and acrylic polymers [9–11].   
Polymeric materials have found vast numbers of applications in different 
biomedical fields. For instance, they have been utilized to create novel drug 
formulations, to develop scaffolds in tissue engineering, to aid bone repair 
processes due to their surface and bulk properties [12,13]. In the last decades, 
novel drug delivery systems have been developed with the recent 
advancements in polymer science. Different polymers used to provide 
controlled release of active pharmaceutical ingredients (API) in constant 
doses over long periods, increase the stability of the API by entrapping it 
within the matrix of the polymer, tune release of both hydrophilic and 
hydrophobic drugs by the swelling, eroding nature of the polymers [14–16]. 
As most abundant natural polymer, cellulose, has been investigated and used 
in pharmaceutical sciences for decades. 
2.1. Cellulose  
Cellulose was used in the form of wood, cotton, 
and other plant fibres for building materials, 
clothing and making paper for hundreds of years 
prior to its discovery by the French chemist 
Anselme Payen in 1838 (Figure 1) [17]. He isolated 
cellulose as solid fibrous material after treating 
plant tissues with acids and ammonia and 
applying extraction with water, alcohol and ether. 
Figure 1. Anselme Payen. 
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He determined the molecular formula as C6H10O5 with elemental analysis and 
the word “cellulose” was first used in 1839 in a report of the French academy 
on the work of Payen [18].  
Cellulose is the most abundantly occurring biopolymer on earth with 1.5 
trillion tons/year biomass production [19]. Cellulose, as renewable natural 
polymer, is found within the plant cell walls and synthesized by some 
bacterial species, algae, fungi and tunicates [20].Among these sources plants 
remain the main source of cellulose.  
Even though cellulose was discovered and isolated from green plants by 
Anselme Payen in 1838, resolving its structure and discovering its polymeric 
nature had to wait until the 20th century [21,22].   
2.2. Cellulose structure  
Plant cell walls consist of primary and secondary cell walls which both 
contain cellulose and hemicellulose within their structure. In addition, 
primary cell walls furthermore contain pectin and secondary cell walls 
include lignin (Figure 2) [23,24].  
 
  
 
 
 
Figure 2. Illustration of structural design of plant cell walls.                                    
(source: http://bioenergy.ccrc.uga.edu/Background/background.htm).  
Cellulose is a carbohydrate polymer constructed from repeating β-D-gluco-
pyranose molecules which are linked by 1,4-β glucoside bonds. In a cellulose 
structure, every second β-D-gluco-pyranose unit (anhydroglucose unit-AGU) 
rotates in a 180 degrees angle to create covalent bonds between hydroxyl 
groups of the C4 and the C1 atoms (Figure 3) [25,26]. 
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Figure 3. Structure of cellulose (n=Degree of polymerization (DP). 
In addition, inter- and intramolecular hydrogen bonds occur due to the 
affinity of hydroxyl groups to each other. These hydrogen-bonding 
interactions contribute greatly to the mechanical strength and chemical 
stability of cellulose by creating different cellulose polymorphs [27]. 
2.3. Cellulose polymorphs  
In the cellulose chain, each AGU unit has three hydroxyl groups which are 
positioned at the C2, C3 and C6 carbons (Figure 3). These OH groups can form 
hydrogen bonds within the same chain via interaction of C2-OH and C6-OH 
groups (intramolecular bond) or with neighbouring chains via interaction of 
C3-OH and C6-OH groups (intermolecular bond). The orientation of these 
hydroxyl groups within single units and the alignment of chains within 
neighbouring chains create different polymorphs of cellulose (and their 
allomorphs), these polymorphs (Iα, Iβ, II, IIII, IIIII, IVI and IVII) are well 
documented in the literature [28,29].  For example, when OH groups at C2 or 
C3 carbons bond to C6-OH of the parallel chain, different crystalline forms of 
cellulose occur, cellulose I and II (Figure 4).  
 
 
 
 
 
 
Figure 4. Positions of intermolecular hydrogen bonds for cellulose I and II.  
cellulose I cellulose II 
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Cellulose I, sometimes referred to as native cellulose, is produced in nature 
by different organisms such as trees, plants, tunicates, algae, and bacteria. The 
crystalline structure of cellulose can have triclinic (cellulose Iα) and monoclinic 
(cellulose Iβ) unit cells. The ratio of cellulose Iα and Iβ in the native cellulose 
depends on the source of cellulose. Native cellulose is thermodynamically 
metastable and can be converted into the most stable form cellulose II or into 
the cellulose III. Cellulose II is formed from cellulose I, either by swelling plant 
fibres in concentrated sodium hydroxide (NaOH) solution (mercerization) or 
by solubilizing cellulose I in liquid ammonia and re-precipitating in water 
(regeneration).  Cellulose IIII and IIIII are formed when cellulose I and II are 
treated in liquid ammonia or some amines. Cellulose IVI and IVII can be 
formed by heating cellulose IIII and IIIII in glycerol at 250 °C, respectively 
(Figure 5) [30–32]. 
 
 
 
 
 
 
 
 
Cellulose has several characteristic properties such as high moisture 
absorbance, good biocompatibility, high thermal stability, relatively low cost, 
high strength and durability and low density yet good mechanical properties. 
However, there are several drawbacks of this most abundant polymer, such 
as its insoluble nature in water and organic solvents, low thermoplasticity, 
high hydrophilicity (can be undesired in specific applications) and lack of 
antimicrobial properties. In order to overcome these drawbacks, cellulose can 
be regenerated or derivatised by different physical and chemical modification 
methods. It can be physically modified by dissolving it in non-derivatizing 
Figure 5. Transformation of polymorphic forms of cellulose.  
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solvent systems or chemically modified by introducing functional groups 
(derivatization). Thus, new desired attributes can be engineered without 
eliminating its desirable properties [33].  
2.4. Cellulose dissolution, shaping, regeneration, 
derivatization  
Cellulose is insoluble in water and most common solvents. The reason behind 
the poor solubility are the strong hydrogen bonds within a cellulose chain and 
also with neighbouring chains. To improve some of the characteristics of 
cellulose including the solubility in water, hydrogen bonds can be weakened 
by dissolving the cellulose in non-derivatizing solvents and derivatizing 
solvent systems and then it can be coagulated, regenerated or modified 
(Figure 6). There are variety of methods to dissolve cellulose and each has its 
own benefits and drawbacks [34–36]. 
 
 
 
 
Figure 6. Classification of cellulose dissolving solvents. 
Different types of solvent compositions can be used as non-derivatizing 
solvent system such as ionic liquids, amine oxides and polar-aprotic-organic 
liquids to dissolve the cellulose. Dissolved cellulose can be coagulated into 
different geometries and properties via dropping or dispersion techniques 
[37–39].   
Derivatizing solvents are used to chemically modify the cellulose by 
functionalizing it with different molecule groups. Thus, the properties of 
cellulose can be tailored for specific industrial applications. Chemical 
modification such as esterification and etherification at the hydroxyl groups 
of cellulose are typical modification process. Fundamental property changes 
can be achieved with these substitution reactions. Oxidation, acetylation, ionic 
and radical grafting and deoxyhalogenation can be given as examples for 
                                                                                 Literature review 
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other chemical modification methods to create cellulose derivatives.  In 
addition, a derivatised cellulose solution can be regenerated as cellulose to be 
used as functional materials in various forms, such as fibres, films, 
membranes, beads, microspheres, hydrogels, aerogels, bioplastics via 
polymer spinning or casting [40,41]. 
2.5. Cellulose based materials for drug delivery 
Cellulose, regenerated cellulose and cellulose derivatives are widely used as 
pharmaceutical excipients. Different forms of pure cellulose can be obtained 
by various manufacturing processes. Powdered cellulose (PC), low 
crystallinity powdered cellulose (LCPC) and microcrystalline cellulose (MCC) 
are examples of different forms of pure cellulose. α-cellulose purification and 
mechanical size reduction is used to manufacture powdered cellulose. 
Microcrystalline cellulose is partially depolymerized cellulose prepared by 
controlled treating of α-cellulose. The shape, size, degree of crystallinity and 
polymerization create the differences between the forms. Powdered cellulose 
and microcrystalline cellulose are used in the formulation of oral solid dosage 
forms as bulking agent in direct compression, or as adsorbent and thickening 
agent in topical formulations. Moreover, MCC is used as tablet binder, diluent 
in wet granulation or in direct compression as tablet disintegrant, anti-
adherent or as capsule diluent. Some of the grades of powdered cellulose is 
available also to be used as binder and disintegrant [3,4,29].  
Regenerated cellulose materials are manufactured by first dissolving the 
cellulose to soluble cellulose derivative and then subsequently regeneration 
by polymer spinning or casting. For example, cellulose can be dissolved in 
alkali and carbon disulphide to make the soluble cellulose derivative called 
viscose. Then, viscose can be reconverted to cellulose by passing it through 
diluted sulfuric acid and sodium sulphate solution. The reconverted cellulose 
undergoes several other processes to remove the sulphur, bleach and add 
plasticizer to form transparent films called cellophanes. The cellophanes are 
used in pharmaceutical packaging due to the good compatibility, elasticity, 
durability [4,37].   
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The most commonly used cellulose derivatives in the pharmaceutical 
industry are cellulose ether and ester derivatives. Cellulose ethers are 
manufactured by replacing the hydroxyl groups in AGUs of cellulose with 
alkyl or substituted alkali groups. This class of cellulose derivatives are mostly 
water soluble and can be used as thickener, binders, film former or lubricant. 
Cellulose ethers can be employed to design matrix tablet where they swell 
and form a hydrogel barrier in contact with water, thus sustained release can 
be achieved. Methyl cellulose (MC), ethyl cellulose (EC), hydroxyethyl 
cellulose (HEC), hydroxypropyl cellulose (HPC), hydroxypropylmethyl 
cellulose (HPMC), carboxymethyl cellulose (CMC) and sodium 
carboxymethyl cellulose (NaCMC) are examples for mostly used cellulose 
ethers [4,42–44].  Cellulose ester derivatives can be generated by using 
different types of derivatizing solvents such as N-alkylpyridinium halides, 
especially N-ethylpyridinium chloride and N-benzylpyridinium chloride 
DMSO/paraformaldehyde. Thus, acetates, butyrates, benzoates, phthalates 
and anthranilic acid esters of cellulose can be generated. Cellulose esters are 
mostly water insoluble and mainly used for osmotic and enteric coating of 
drug formulations.  Cellulose acetate (CA), cellulose acetate phthalate (CAP), 
cellulose acetate butyrate (CAB), cellulose acetate trimelitate (CAT), 
hydroxypropylmethyl cellulose phthalate (HPMCP) are commonly used 
cellulose esters in the pharmaceutical industry [4,45–47]. 
2.5.1. Cellulose beads as drug carrier 
As it is described above, cellulose based materials with different 
characteristics can be manufactured and used to formulate different types of 
drug formulations depending on the needs of the final formulation. Cellulose 
pellets and granules are produced from cellulose or cellulosic materials, 
mainly by extrusion, spheronization and subsequent exposure to mechanical 
stress to obtain a spherical shape  [48]. However, there are physical and 
chemical differences between the spherical bead like particles produced from 
cellulose suspension and from cellulose solution. For example, the 
microscopic morphology, pore size, distribution, surface area and functional 
groups may differ at the end product by using these different production 
techniques [5,40]. In addition, producing cellulose beads from cellulose 
                                                                                 Literature review 
10 
 
solution eliminates the energy consuming procedures such as extrusion, 
spherization, thus they can be cost effective, too.  Therefore, we have 
investigated drug carrier potential of novel cellulose beads which were 
manufactured by dissolving cellulose in environmentally friendly dissolution 
and shaping them by coagulation in acidic medium.  
2.5.2. Cellulose disc for oromucosal drug delivery 
Different types of drug formulations have been investigated and used in 
oromucosal drug delivery such as solutions, pastes, ointments, films, tablets. 
However, solutions, sprays or pastes possess some limitations, such as 
unintentional swallowing of the active ingredient, continuous dilution with 
salivary flow, and short duration at treatment site causing extended treatment 
periods [49,50]. However, unidirectional release from mucoadhesive films, 
patches or tablets with various properties (swelling, non-swelling, bilayered) 
can overcome the drawbacks mentioned above, and thus these formulations 
have been investigated and reported in the literature, extensively [51–53].  
Cellulose derivatives such as HPC, HPMC, HEC, CMC are employed to 
manufacture formulations which are suitable for buccal administration due to 
their mucoadhesivity, hydrophilicity and swelling properties [49]. However, 
to the best of our knowledge, no study exists, which uses the non-dispersing 
buccal patches, made out of dissolved cellulose which were produced via a 
novel environmentally friendly method. Therefore, the potential of cellulose 
discs as patch like drug carrier for oromucosal drug delivery needed to be 
explored and investigated.  
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3. Aims of the study 
The aim of this thesis was to investigate the potential of cellulose beads and 
discs as drug carriers and introduce these novel excipients which have a 
tailorable specific surface area and high porosity, uniform volume, weight, 
shape, and ionic charge for pharmaceutical applications.  
 
The specific objectives of the thesis were: 
1. To study loading freely soluble APIs into physically modified cellulose 
beads and investigate the potential of controlling the drug release (Article I). 
 
2. To study entrapment of cationic drugs into chemically modified cellulose 
beads (anionic cellulose beads) and drug release properties from these beads 
which had different oxidation time, thus different amount of anionic groups 
(Article II&III).  
 
3. To investigate the potential of cellulose discs as drug delivery systems for 
buccal treatment (Article IV). 
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4.  Materials and methods 
More detailed description of materials and methods used in this work can be 
found in original publications (I-IV). 
4.1 Materials 
4.1.1. Drug carriers; cellulose beads and discs 
Non-ionic and anionic CBs were received ready from Fibre and Cellulose 
Technology laboratory, Åbo Akademi University, Finland.   
Cellulose discs were created from 5% cellulose solution in the Pharmaceutical 
Science laboratory, Åbo Akademi University, Finland. 
4.1.2. Active pharmaceutical ingredients 
Active pharmaceutical ingredients (API) with different aqueous solubilities 
were riboflavin 5`-phosphate sodium (RSP) (Fluka Analytical, Sigma Aldrich, 
France), lidocaine hydrochloride monohydrate (LiHCl) (Sigma Aldrich, India) 
and anhydrous theophylline (Thp) (Orion Pharma, Finland). They were used 
for the loading of non-ionic CBs (Article I). Ranitidine HCl (RaHCl) (Sigma 
Aldrich, Germany) was used as cationic API in Article II-III to incorporate into 
anionic CBs. In the case of cellulose discs (CDs), lidocaine hydrochloride 
monohydrate and triamcinolone acetonide (TAA) (Fagron, Italy) were used 
as model APIs (IV).  
4.1.3. Shrinkage preventing co-polymers and other substances 
The other components used in the Article IV to avoid shrinkage were 
polyethylene glycol 400 (PEG 400) (Fluka Analytical, Sigma Aldrich, 
Germany), polyethylene glycol 6000 (PEG 6000) (Aldrich Chemistry, Sigma 
Aldrich, Germany), triethanolamine (TEA) (Fluka, Biochemika, Sigma-
Aldrich, Switzerland), propylene glycol (PG) and ethyl cellulose (EC) (Sigma 
Aldrich, Germany). In addition, PEG 6000 and PEG 400 were also used in 
solubility enhancement studies. 
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4.2. Methods 
4.2.1. Preparation of non-ionic cellulose beads (I) 
The detailed preparation method of non-ionic cellulose beads used in this 
study can be found in the literature  [40].  It can be described briefly as follows; 
first pretreated dissolving pulp was dissolved in a 7% NaOH-12% urea-water 
solution so that the dry content of cellulose was 5% in the solution. Later, the 
5% cellulose solution was extruded through a 50 mm long needle with 
diameter of 0.8 mm and dropped into various nitric acid solutions with 
different molarity and temperature from 1-2 cm above to form spherical 
cellulose beads by coagulation (Table 1). Three different types of CBs were 
prepared by controlling the temperature and concentration of the coagulation 
media. 5% cellulose solution were dropped into 25 °C 0.5 molar, 25 °C 2 molar 
and 50 °C 2 molar HNO3 solution to form type 1, 2 and 3 CBs, respectively.  
The beads were left in the acidic solution for 2 hours to ensure complete 
coagulation. In addition, the physical properties of these CBs are presented in 
Table 1 [54]. 
Table 1. Physical properties of three different types of beads [54,55]. 
Type 
of 
CBs 
cHNO
3 
and 
temperature of 
HNO3 solution 
Specific 
Surface area 
m2.g-1  
Water 
swollen 
Volume  
mm3/bead 
Water 
swollen 
Weight     
mg/bead 
Porosity              
%/bead 
T1 0.5 M, 25°C 470 11.2 14.1 93.6 
T2 2 M, 25°C 447 14.9 17.0 93.8 
   T3 2 M, 50°C 381 17.2 17.8 94.7 
 
The coagulated CBs were washed for at least 4 hours under running tap water. 
This procedure was followed by several washing cycles with distilled water. 
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4.2.2. Preparation of anionic cellulose beads (II-III)  
Anionic CBs were prepared from never dried water swollen (type2, T2) 
non- ionic cellulose beads. The  detailed explanation of the preparation 
method of these negatively charged CBs can be found in Article II [56] . It can 
be described briefly as follows; intensively washed and water swollen 
cellulose beads were immersed into a TEMPO/NaClO2/NaClO solution for 2, 
5, 24 and 48 hours at 20, 40, 60 and 80 °C for oxidation.  Only cellulose beads 
which were oxidized for 48 hours at 20, 40 and 60 °C were washed thoroughly 
and were used for drug entrapment and release studies [56,57]. 
Some properties of anionic CBs such as porosity, amount of carboxylic groups 
and re-swelling abilities in sodium phosphate buffers with different pH 
values were investigated and the results are presented in Table 2. In addition, 
the porosity of the all samples was found to be between 94% and 95%.  [56,57].  
Table 2. Properties of non-oxidized and oxidized beads [56,57].  
Type Oxidation 
temperature for 
48 hours 
Amount of 
carboxylic acid 
groups                      
mmol.g-1  
Re-
swelling 
in pH 1.2     
% 
Re-
swelling 
in pH 3.6     
% 
Re-
swelling 
in pH 7.4     
% 
CB (T2) NA 0.1 54.6 52.7 49.5 
OCB20 20 °C 0.92 57.1 63.0 77.8 
OCB40 40 °C 1.23 56.5 64.3 85.3 
  OCB60 60 °C 1.85 54.7 64.9 87.8 
 
4.2.3. Preparation of cellulose discs (IV) 
A 5% cellulose solution, which was prepared by dissolving pretreated pulp in   
7 % NaOH-12 % urea–water at –10 °C, was received ready from Fibre and 
Cellulose Technology laboratory, Åbo Akademi University, Finland and used 
for the manufacturing of cellulose discs. 
There are several parameters affecting the formation of CDs in nitric acid, 
such as the dropping height, temperature and the molarity of the coagulation 
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medium [54,55]. Therefore, two of those formation determining parameters 
were investigated to obtain CDs; the molarity of the coagulation medium and 
the drop height of the cellulose solution. Four different molarities (0.3, 0.5, 0.7 
and 1 molar) for the coagulation medium and five different drop distances (1, 
3, 7, 10 and 15 cm) as dropping height were investigated by changing one 
factor at the time. Instead of manual dropping of the solution by a pipette, 
gravitational dropping using a Mohr pipette was chosen to have minimum 
weight and volume variation among the created discs. Coagulated CDs were 
left in the nitric acid solution for 1–2 minutes for successful formation of 
cellulose discs. The nitric acid, urea and NaOH were removed by washing 
under tap water flow for approximately 2 hours and several washing cycles 
with ethanol were performed to change the water in the CDs with ethanol. 
4.2.4 Drug incorporation into cellulose beads (I-III) 
Undried, empty, water swollen CBs were loaded with model drugs by 
immersion technique, i.e. model drugs were dissolved in distilled water and 
empty CBs were immersed into drug loading solutions so that there would be 
2 beads per ml of the loading solution. The concentration of the drug loading 
solutions and the types of CDs used are presented in Table 3. APIs; Thp, RSP 
and LiHCl. After the immersion, the loading solutions were gently agitated 
with a magnetic stirrer for 24 hours. After the loading was completed, loaded 
CBs were dried on a glass plate at constant temperature and humidity 
(22.5 °C, 50 %) for at least 48 hours until there was no change in the mass of 
the loaded CBs. 
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Table 3. Summary of the model drugs, drug loading concentrations and cellulose 
bead types [55–57] 
Article No Model drugs Drug loading 
concentrations 
mg/ml 
CB types 
used for 
loading 
Article I 
Thp 4  
3 
2 
1 
   RSP 
20  
3 
2 
1 
4  
3 
2 
1 
LiHCl 
20  
3 
2 
1 
4  
3 
2 
1 
Article II & III RaHCl 20  
OCB0 (T2) 
OCB20 
OCB40 
OCB60 
 
 
4.2.5 Drug incorporation into cellulose discs (IV) 
Drug loading solutions were prepared by dissolving the APIs in polymer-
ethanol solutions. Three different API concentrations (5, 20 and 80 mg/ml for 
LiHCl and 0.5, 1 and 2 mg/ml for TAA) and six different PEG 6000:PEG 
400:ethanol weight ratios were used to prepare the drug loading solutions. 
Table 4 presents the overview of drug loading solution compositions and 
concentrations.  
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Table 4. Summary of the model drugs, drug loading concentrations and compositions 
[58]. 
Model drug 
Drug 
concentration 
mg/ml 
Polymer-ethanol ratios                      
%-weight 
Coding 
(abbr. for the 
formulations) PEG 6000 PEG 400 Ethanol 
LiHCl 
80 
50 0 50 L80-50:0:50 
35 15 50 L80-35:15:50 
25 25 50 L80-25:25:50 
15 35 50 L80-15:35:50 
0 50 50 L80-0:50:50 
0 0 100 L80-0:0:100 
20 
50 0 50 L20-50:0:50 
35 15 50 L20-35:15:50 
25 25 50 L20-25:25:50 
15 35 50 L20-15:35:50 
0 50 50 L20-0:50:50 
0 0 100 L20-0:0:100 
5 
50 0 50 L5-50:0:50 
35 15 50 L5-35:15:50 
25 25 50 L5-25:25:50 
15 35 50 L5-15:35:50 
0 50 50 L5-0:50:50 
0 0 100 L5-0:0:100 
TAA 
2 
50 0 50 T2-50:0:50 
35 15 50 T2-35:15:50 
25 25 50 T2-25:25:50 
15 35 50 T2-15:35:50 
0 50 50 T2-0:50:50 
0 0 100 T2-0:0:100 
1 
50 0 50 T1-50:0:50 
35 15 50 T1-35:15:50 
25 25 50 T1-25:25:50 
15 35 50 T1-15:35:50 
0 50 50 T1-0:50:50 
0 0 100 T1-0:0:100 
0.5 
50 0 50 T0.5-50:0:50 
35 15 50 T0.5-35:15:50 
25 25 50 T0.5-25:25:50 
15 35 50 T0.5-15:35:50 
0 50 50 T0.5-0:50:50 
0 0 100 T0.5-0:0:100 
                                                                                 Materials and Methods 
18 
 
Undried, ethanol swollen CDs were immersed into these solution (one disc 
per ml) and gently agitated with a magnetic stirrer for 24 hours. In the case 
where PEG 6000 was used, the drug loading process was performed at 55 °C 
in a water bath due to the melting point of PEG 6000 (Tm= 55-60 °C)  [59]. After 
the loading, loaded CDs were dried on a glass plate at constant temperature 
and humidity (22.5 °C, 50%) for at least 48 hours until there was no change in 
the mass of the loaded CDs. 
4.2.6 Drug content analysis (I-IV)  
To be able to extract the all the incorporated drug content, first, the loaded 
never dried CBs were mechanically crushed into small pieces and immersed 
into 100 ml of distilled water. In the case of the loaded CDs, the crushed pieces 
were immersed into 10 ml ethanol solution due to the low solubility of TAA 
in water. Then, the solutions which had the crushed CDs & CBs were stirred 
with magnetic stirrer for 24 hours at room temperature until CBs & CDs were 
fibrillated. Fibres were separated from the supernatant by centrifugation 
(4500 rpm, 5 minutes). After the centrifugation, the amount of drug 
incorporated into the CBs was examined spectrophotometrically by 
measuring the UV light absorption of the solutions with a UV/Vis 
spectrophotometer (PerkinElmer, Lambda 25, Germany) at fixed wavelength; 
267 nm for RSP, 218 nm for LiHCl, 267 nm for Thp, 228 nm for RaHCl, 218 nm 
for LiHCl and 239 nm for TAA (see Table 5). Each sample was analysed in 
triplicate for all cases. The table below presents the model drugs, used 
wavelengths and solvents in the respective articles. 
Table 5. Model drugs, wavelengths and solvents used to determine the drug content 
in CBs and CDs [55–58]. 
 
 
 
 
 
Article No Model drugs Wavelength 
nm 
Solvent 
Article I 
RSP 267 
water 
LiHCl 218 
Thp 267 
Article II & III RaHCl 228 
Article IV 
LiHCl 218 
ethanol 
TAA 239 
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Furthermore, to measure any possible effects of the remaining cellulose fibres 
in the solutions on the absorbance, empty CBs and CDs were immersed and 
crushed in water and ethanol respectively and then centrifuged under the 
same conditions as mentioned above. Also, two times more than the 
maximum PEG 6000 and PEG  400 amount which were entrapped in the CDs 
were dissolved in ethanol and the absorbance measured at 218 and 239 nm. 
There was no absorbance interference of the remaining fibres or polymers at 
the wavelengths used for the detection of the drug substances.  
4.2.7 In-vitro drug release studies (I-IV) 
The in vitro drug release for the loaded CBs was performed according to the 
USP paddle method (United States Pharmacopeia, 35th Ed.). The number of 
the beads used for the dissolution experiments for each study was chosen 
carefully in order to stay within sink conditions in the dissolution media even 
if there would be a 100% drug release from all the beads. The 500 ml 
dissolution media were 0.1 N HCl buffer solution (pH 1.0) and sodium 
phosphate buffer (pH 1.2, 3.6 and 7.4). The in-vitro drug release experiments 
were performed with the Sotax AT7 smart dissolution tester (SOTAX, 
Switzerland), thus sampling was done automatically. 
In the case of the cellulose discs, drug and polymer loaded and dried CDs, 
which were covered with ethyl cellulose film from one side, were immersed 
into glass vessels filled with 50 ml phosphate buffer (pH 6) at 37 °C. A 
thermostatic water bath (Julabo SW22, Germany) was used to preserve 37 °C 
during the analyses. 100 rpm was chosen as shaking speed. The sample 
collection was performed manually at specific time intervals for 4 hours. The 
collected sample volume was replaced by an equal volume of fresh buffer 
solution. 
The drug release amounts at the different time intervals were measured by 
using a UV/Vis spectrophotometer (PerkinElmer, Lambda 25, Germany). The 
absorption was measured at fixed wavelengths: 267 nm for RSP, 218 nm for 
LiHCl and 272 nm for Thp (I), 228 nm for RaHCl (II-III), 218 nm for LiHCl and 
242 nm for TAA (IV). All the experiments were done in triplicate (n = 3).  
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Table 6 summarizes the model drugs, wavelengths, dissolution media and 
volumes used for in-vitro drug release studies for each article.  
Table 6. Model drugs, wavelengths , dissolution medium and volume used to 
investigate the drug release from CBs and CDs [55–58]. 
Article No Model drugs Wavelength 
nm 
Dissolution 
medias 
Dissolution 
volume 
Article I 
RSP 267 
0.1 N HCl buffer 
solution (pH 1) 
500 ml 
LiHCl 218 
Thp 267 
Article II  RaHCl 
228 
sodium phosphate 
buffer (pH 7.4) 
Article III RaHCl 
228 
sodium phosphate 
buffer (pH 1.2 & 
3.6) 
Article IV 
LiHCl 218 
potassium 
phosphate buffer 
(pH 6) 
50 ml 
TAA 242 
  
4.2.8 Morphology studies with field emission scanning electron 
microscopy (FE-SEM) (I & IV) 
The surface and interior morphology of empty and loaded dried cellulose 
beads and discs were investigated by using the Leo Gemini 1530 field 
emission scanning electron microscope (FE-SEM) with an In-Lens detector. 
The samples were carbon coated with the Tamcarb TB500 sputter coater 
(Emscope Laboratories, Ashfold, U.K) prior to FE-SEM observation. Then, the 
optimum accelerating voltage of 8 kV (I) & 10 kV (IV) was used to obtain 
FE- SEM images and the magnifications used were between 30x (I-IV), 500x 
(IV) and 10kx (I).  
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4.2.9 Solid state characterization  
4.2.9.1 Fourier transform infrared (FTIR) & 
Raman spectrometer (II-III)  
ATR/FTIR and Raman spectra of empty non-ionic and anionic cellulose beads 
were collected by using a Nicolet iS 50 FT-IR spectrometer which has a Raman 
module (Thermo Fisher Scientific, USA). Tungsten-Halogen source and 
DLaTGS-KBr detector-splitter with 4.000 cm-1 resolution and 64 scans were 
used to collect spectra during FTIR analyses. During the Raman analyses, a 
diode laser was used as source and a InGaAs-CaF2 detector-splitter with 
8.00 cm-1 and 1,024 scans was used for spectra collection. Gold plates were 
used during the Raman measurements. 
4.2.9.2 Differential scanning calorimeter (DSC) (III-IV) 
DSC Q2000 (TA Instruments, USA) was used to understand the solid state of 
the model drugs in the cellulose beads and discs. In article III, empty and 
loaded anionic and non-ionic CBs, pure RaHCl; in article IV, pure model 
drugs, polymers, physical mixtures and empty-loaded cellulose discs were 
subjected to DSC measurements. The samples were placed in aluminium T-
zero pans (for solid samples) and in hermetic pans for (liquid samples) over a 
temperature range between 20-300 °C with a heating rate of 10 °C/min. 
Nitrogen as inert gas was used during the measurements at the flow rate of 
50 ml/min. 
Moreover, DSC analyses were performed on washed and unwashed CDs to 
prove the removal of residual nitric acid after precipitation of the CDs (IV).  
 
4.2.10 Other analyses performed on CBs and CDs  
4.2.10.1 Hyperspectral NIR imaging on CBs-drug distribution (I) 
The empty and loaded cellulose beads (I) were dissected with a doctor blade 
for the analysis of the internal structure. Drug distribution within the loaded 
dried cellulose beads was studied by collecting hyperspectral NIR images 
with the hyperspectral, a chemical imaging workstation SisuCHEMA 
(SPECIM, Spectral Imaging Ltd, Oulu, Finland), which utilizes a SPECIM 
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MCT based Spectral Camera. Multivariate visualizations were conducted 
with the Evince (Umbio AB, Sweden) software. 
4.2.10.2 Mechanical tests on CDs, strength and mucoadhesion (IV) 
A Texture analyser (TA.XTplus, Stable Micro Systems, UK) was used to 
determine the hardness and mucoadhesion properties of the bilayered CDs. 
Hardness studies were performed by applying force on the bilayered CDs 
with a 20 mm diameter cylindrical aluminium probe at 1 mm/sec speed. All 
measurements were performed at ambient conditions in triplicate. The results 
were compared with the marketed buccal tablet, Aftab (MedaPharma, 
Germany). For mucoadhesion studies, loaded CDs were attached to 
aluminium cylindrical probe and then brought in contact with the porcine 
tongue tissue. The tongue was wetted with filtered human saliva and with a 
phosphate buffer (pH 6). In addition, the tongue was kept in phosphate buffer 
(pH 6) at 37 °C thus the tissue could be kept at a constant temperature to 
mimic the oral conditions. The probe with the sample were moved toward the 
tongue with 0.5 mm/s pre-test speed and when the probe reached the tissue, 
it was held in place for 3 seconds for Aftab and 60 s for the CDs with 2 kg load 
power.  The reason for time difference was due to the low mucoadhesion of 
the CDs, since the 3 seconds contact time for the CDs did not result in any 
significant value. After pressing the samples which were on top of the probe, 
to the tissue, the probe was withdrawn at a speed of 0.5 mm/s to a distance of 
15 mm. The Texture Exponent 32 software were used to calculate the 
detachment force with respect to time (adhesion impulse, unit N.s). The 
collected data was used to compare the mucoadhesion of the formulation with 
the marketed product. 
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5. Results and discussions 
5.1 Properties of non-ionic and anionic CBs (I-III) 
Porosity, volume, specific surface area of non-ionic CBs (I) and ionic charge, 
re-swelling abilities, porosity of the anionic CBs (II-III) are significant physical 
properties since they can have a direct influence on the drug entrapment 
capacity of CBs, the drug release from CBs and the solid state of drugs within 
CBs (Table 1, 2). These properties have been discussed below. 
In the process of creating non-ionic cellulose beads, coagulation happened 
faster when the molarity of the coagulation media was kept constant and the 
temperature altered from 25 °C to 50 °C. This caused the skin layer to become 
thicker and firm faster, thus the dimensions of the droplet were preserved. 
Since bigger beads could hold more water inside, the weight and volume 
increased. In addition, the porosity increased due to a higher proportion of 
micro and small mesopores (2-50 nm) at 25 °C and macropores at 50 °C [54]. 
On the other hand, when the temperature was kept constant, but the molarity 
was altered, it was observed that coagulation in nitric acid solution with lower 
molarity resulted in denser internal structure and coarser surface morphology 
since aggregation continued for a longer time within the beads. Higher 
molarity of nitric acid resulted in faster coagulation and intercepted the 
aggregation of the cellulose fibrils. Thus, decrease in porosity, water swollen 
volume and weight was observed with the CBs coagulated in 0.5 molar 
compared to the beads which were coagulated in 2 molar nitric acid solution. 
On the contrary, the specific surface area of CBs decreased with the molarity 
and temperature rise. Slow diffusion and continuous agglomeration processes 
occurred when nitric acid with low temperature and molarity was used, thus 
cellulose molecules arranged themselves into specific internal structures 
which resulted in maximized specific surface area [54].  It could be expected 
that cellulose beads with higher water swollen volume and weight can be 
loaded with higher drug amounts since there would be more space within the 
empty beads for the drug loading solution to diffuse. However, a decrease in 
the specific surface areas while weight and volume increase can affect the 
drug entrapment and drug release negatively due to less surface to attach for 
the drug molecules.  
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The amount of anionic groups within the oxidized CBs were elevated when 
the temperature of the oxidation reaction was increased from 20 to 60 °C and 
the time of reaction elevated from 2 to 48 hours (see Table 2).  The reason 
behind the increase in the amount of anionic groups is that specific oxidation 
of C6 hydroxyl groups by N-oxoammonium ions occurs more efficiently when 
higher temperatures and longer time were employed during the oxidation 
[56]. In addition, higher amount of anionic groups resulted in higher re-
swelling abilities in the dissolution medium with high pH. However, there 
was no significant change in the porosities of anionic CBs when oxidization 
conditions were altered. 94-95% porosity was observed within all oxidized 
samples [56,57].  It was expected that cellulose beads which were oxidized for 
a longer time period can entrap higher amount of cationic drug molecules, 
since the amount of anionic groups within the beads was increased and the 
bonding of these negatively charged groups with a positively charged drug 
would be higher. In addition, higher re-swelling in a high pH medium could 
result in faster drug dissolution since the pores would enlarge more and the 
entrapped drug could diffuse easier into the dissolution medium. 
5.2 Formation of cellulose discs and their shape (IV) 
5 % cellulose solution, was dropped from five different heights into the nitric 
acid coagulation medium with five different molarities. These parameters 
were altered to find out the optimal dropping height and coagulation medium 
molarity to create the desired CDs. The experiments showed that higher 
molarities than 0.7 molar resulted in thicker and bead like structures 
regardless of the dropping height due to faster skin formation due to the high 
molarity of the coagulation media. However, when the molarity was 0.7 molar 
and lower, flatter and disc shape cellulose formations could be created 
because of slow coagulation and skin formation. After the molarity was 
chosen as 0.7 molar, the effect of the drop height was investigated. When the 
dropping distances were 1 and 3 cm hollow bead like shapes were formed and 
at the drop height of 10 and 15 cm, the discs got uneven edges due to increased 
surface impact of the nitric acid medium. The dropping height of 7 cm 
resulted in flatter disc-like shapes (Figure 7). 
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Figure 7. A. Dropping height effect of cellulose disc formation. B. Cellulose discs 
formation with 7 cm dropping height, coagulation media 0.7 molar nitric acid. 
In addition to the dropping height and the molarity of coagulation medium, 
the dropping method was investigated to create uniformly shaped cellulose 
discs. Manually dropping the cellulose solution with an automatic pipette 
created greater a weight deviation while forming cellulose solution drops. 
However, dropping the solution with a Mohr pipette and using the 
gravitational force created cellulose discs with a uniform weight distribution. 
Therefore, cellulose discs used in this study were produced by employing the 
later mentioned dropping method [58]. 
 
5.3 Morphological studies (FE-SEM) 
5.3.1 Cellulose beads (I-III) 
Empty dried CBs and drug loaded dry CBs had a regular spherical shape with 
an average size of 1 mm. FE-SEM analyses proved that there is a significant 
difference between the internal structure of empty and loaded CDs (Figure 8 
A-B).  
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Figure 8. Internal morphology of an unloaded (A) and lidocaine loaded beads (B) 
magnification: 100×, 200×, respectively. External/surface morphology of an unloaded 
(C) a lidocaine loaded bead (D), magnification 100×, 200×, respectively [55]. 
The pores of empty beads (Figure 8 A) were filled with the model drug 
compounds and there was no observable crystallization within or on the 
surface of the beads (Figure 8 B-D). In addition, it can be stated that the 
concentration of the loading solution, type of the beads and the selected model 
drugs did not have a noticeable effect on the external surface morphology of 
the beads (Figure 8 C-D). 
The oxidization process resulted in reduction of big agglomerates which were 
observed in non-ionic CBs [54,56]. In addition, opening of agglomerates was 
observed along the cross section of oxidized CBs regardless of the distance 
from the edges or the oxidation conditions. Thus, opening of agglomerates 
resulted in even distribution of anionic groups within the CBs and changed in 
pore size distribution compared to the non-ionic CBs [56] 
5.3.2 Cellulose discs (IV) 
FE-SEM studies on dried empty CDs, only polymer containing CDs and drug-
polymer loaded CDs indicated that PEG 6000 and PEG 400 embedded in the 
voids within the CDs (see Figure 9 A-D). Similar findings were reported in the 
literature, when PEG 400 and PEG6000 were loaded into porous CBs [60]. 
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Figure 9. A,B. Empty dried CDs, 10x-500x. C,D CDs loaded in PEG 
6000:PEG400:EtOH solution (15:35:50 w:w:w %), dried, contains no drug,  10x-500x.  
E,F. Partial crystallization of LiHCl on the surface of CDs loaded in PEG 
6000:PEG400:EtOH solution (15:35:50 w:w:w %) with 80 mg/ml LiHCl concentration, 
dried, 10x-500x G,H Surface of CDs loaded in PEG 6000:PEG400:EtOH solution 
(15:35:50 w:w:w %) with 1 mg/ml TAA concentration, dried, 10x-500x.   
In addition, partial crystallization of LiHCl on the surface of the loaded CDs 
was observed due to the high loading concentration of this model drug (see 
Figure 9 E-F). No crystallization was observed when the drug loading 
concentration of LiHCl was lower than 80 mg/ml or when TAA was loaded 
with in the CDs with 2, 1 and 0.5 mg/ml concentrations (see Figure 9 G-H).  
5.4 Assay of drug content 
5.4.1 Cellulose beads (I-III) 
The amount of entrapped drug within the beads correlated with the drug 
loading concentration and the water swollen volume and porosity of the 
beads (Table 7). The incorporated drug amount was increased from the bead 
type 1 to 3 where the water swollen volume-weight and porosity was highest. 
In addition, the loading efficiency was affected by the water solubility of the 
APIs. The amount of incorporated Thp was lower than for the other model 
drugs due to lower water solubility of Thp.  
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Table 7. Drug loading shown as the amount of drug incorporated per one bead and 
as mass percentage. Uniformity of drug loading is also presented as variation in the 
amount of drug loaded per one bead (n=5).  
Model 
drug 
Drug loading 
concentration 
mg/ml 
Bead typea Incorporated drug 
amount in one 
bead                        
mg 
Drug amount 
percentage per 
one dry bead  
 % 
Thp 
4 T3 0.072 ± 0.002 5.0 
4 T2 0.052 ± 0.002 4.2 
4 T1 0.049 ± 0.004 3.7 
LiHCl 
20 T3 0.396 ± 0.032 27.3 
20 T2 0.333 ± 0.050 26.6 
20 T1 0.313 ± 0.052 23.2 
4 T3 0.118 ± 0.022 8.1 
4 T2 0.095 ± 0.036 7.6 
4 T1 0.065 ± 0.008 4.8 
RSP 
20 T3 0.207 ± 0.005 14.3 
20 T2 0.163 ± 0.015 13 
20 T1 0.172 ± 0.038 12.7 
4 T3 0.081 ± 0.005 5.6 
4 T2 0.063 ± 0.002 5.1 
4 T1 0.068 ± 0.002 5 
athe average weights of empty dried T1, T2 and T3 beads were 1.35, 1.25 and 1.45 mg, 
respectively, n=25. 
The observed correlation between drug content in the beads and drug loading 
concentration, porosity, water swollen weight and volume was qualitatively 
predictable. Since the drug could diffuse into empty CDs more when the 
concentration gradient was higher and the porosity was higher, the volume 
had increased the entrapment ability of the CDs too.  
In the case of anionic CBs (II & III), it was found that oxidation has widened 
the cavities (small meso and macropores) within the beads, opened some of 
the closed pores by opening agglomerates and increased the anionic groups 
within the beads [56,57].  
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Table 8. Drug loading shown as the amount of drug incorporated per one bead and 
as mass percentage. Uniformity of drug loading is also presented as variation in the 
amount of drug loaded per a one bead. 
Model 
drug 
Drug loading 
concentration 
mg/ml 
Bead typea Incorporated drug 
amount in one bead  
mg 
Drug amount 
percentage per 
one bead  
 % 
RaHCl 
20 OCB0 (2) 1.13 ± 0.01 20.7 
20 OCB20 1.18 ± 0.01 17.8 
20 OCB40 1.77± 0.01 25.8 
20 OCB60 1.49 ± 0.01 21.8 
a the average weights of empty water swollen OCB0 (2), OCB20, OCB40 and OCB60 beads were 
4.33, 5.43, 5.09 and 5.34 mg, respectively, n=50.  
The amount of ranitidine HCl incorporated into the matrix system of the CBs 
increased when the cavities within the bead were widened and the amount of 
carboxylic groups (anionic groups) in the beads was increased by higher 
degree of oxidation (Table 8). However, a decrease was observed in the total 
amount of the drug in the beads, which were oxidized at 60 °C (OCB60). A 
possible explanation for this might be the higher amount of bounded water 
within the mass of empty OCB60 [57]. Moreover, the difference in the weight 
of empty beads resulted in a variation of the drug amount percentage per bead 
between 17.8% and 25.8% (Table 8). 
5.4.2 Cellulose Discs (IV) 
Two model drugs, LiHCl as freely water-soluble API and TAA as poorly 
water-soluble API were incorporated into CDs by immersion technique as 
described in section 4.2.3 (Table 4). The aim of investigating different drug 
concentrations and solvent ratios was to understand the significance of these 
parameters on drug intake and drug release.  The average content of LiHCl 
and TAA in the CDs is presented as bars in Figure 10.    
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Figure 10. Amount of LiHCl and TAA in loaded cellulose discs (A, B, respectively) 
where CDs had been loaded in drug loading solutions with three specific drug 
concentrations and six different PEG 6000:PEG400:EtOH solvent composition  ratios, 
presented in legends (n = 3). 
The results presented in the graphs show that there was a significant positive 
correlation between the drug loading concentration and the drug content 
within the beads. In addition, it is important to state that the solubility of APIs 
is also a limiting factor on the loading efficiency within the beads since the 
drug loading concentration is limited by that factor, too. A similar finding was 
observed in the previous studies that have examined the effect of the drug 
loading concentration on the drug content in the drug carriers [55].  
Moreover, Modde (Umetrics AB, Sweden) as a design of experiment software 
was used to mathematically identify the influence of drug loading solution 
concentration, polymer type and interaction factors (drug loading 
concentration*polymer type considered together) on the drug content 
(response) within the discs. The software performs the task by fitting a 
polynomial model to the data (factors and response values) and then 
determining the numerical values of the model parameters (regression 
coefficients). These coefficients used to understand how significantly the 
factors influence the response. Polynomial model can be summarised with the 
equation: 
      (Eq. I) 
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where y is the response, x are the factors, β0 is the constant term, β are the 
model parameters, and ε the residual response. For the data we obtained, 
when the factors and response values were entered into the software and 
scaled-centred regression coefficients of the polynomial model for CDs were 
evaluated. All the other regression coefficient values were smaller than the 
uncertainty coefficients (confidence intervals) except the regression coefficient 
of the drug loading concentration, thus we can once more conclude that effect 
of the polymer type on the drug content in the CDs was not significant within 
these sets of variables and drug concentration ranges. The concentration of 
drug loading solution was the only major factor influencing the drug content 
and correlating with it.  
The drug contents in the final formulations were chosen to be at the same level 
as in similar commercial products. For example, Kamistad N is an oral gel 
with 20 mg/g LiHCl concentration and the approximate amount of applied gel 
on aphtha would contain 2 mg LiHCl (PIL of Kamistad N describes three 
times a day on 0.5 cm surface). Moreover, the marketed mucoadhesive tablet, 
Aftab contains 25 µg TAA. Since the final formulation of CDs was covered 
with EC film from one side to obtain a unidirectional release to the aphtha 
side and CDs were aimed to be kept at the site of action for four hours, the 
drug dose in the final formulation in the CDs was aimed to be approximately 
two times higher than the marketed products (4 mg for LiHCl and 50 µg for 
TAA). Therefore, the CDs were loaded in the drug loading solutions with 
concentrations of 80 mg/ml and 1 mg/ml for LiHCl and TAA, respectively. 
Once the drug loading concentration was chosen, the Modde software was 
used to study how the drug content varies as a function of PEG 6000, PEG400 
and ethanol (Figure 11). 
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Figure 11. Mixture contour plots for CDs, which were loaded in 80 mg/ml LiHCl and 
1 mg/ml TAA solutions. Both mixture contour plots illustrate the changes in the drug 
content when PEG 6000, PEG400 and EtOH ratios have been altered from 0 to 50% 
and sum up to 100%. 
All the drug loading solutions with different PEG 6000: PEG 400: ethanol 
ratios can give the desired drug dose in CDs, 3.2-4.2 mg and 50-60 µg for 
LiHCl and TAA respectively (Figure 10). We can conclude that the polymer 
concentrations in the drug loading solutions do not have a significant 
influence on the drug diffusion into the cellulose discs since the size of all 
polymer molecules used was small enough to diffuse through macropores. 
Therefore, it was decided that CDs which were immersed in 80 mg/ml for 
LiHCl and 1 mg/ml for TAA solutions with different PEG 6000:PEG400:EtOH 
ratios must be analysed further. All the formulations created need to be 
analysed further to decide which formulation can give the desired release and 
mechanical properties. 
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5.5 In-vitro drug release kinetics   
5.5.1 Non-ionic cellulose beads (I) 
The release profile of Thp loaded CBs reveals an initial burst release followed 
by a steady release. However, RSP loaded CBs showed a prominent difference 
since the burst release was not observed here and only a steady release of the 
API could be seen (Figure 12). The reason behind this phenomenon can be 
attributed to the low solubility of RSP in the studied dissolution medium 
(2 mg/ml). In the case of LiHCl loaded beads, the pure substance was released 
totally after 30 minutes in 0.1 N HCl solution. Even though LiHCl is a freely 
water-soluble substance, the common ion affect decreased the solubility of the 
substance in the medium thus the release rate was slower. Moreover, LiHCl 
was not released totally from the matrix. The reason behind that phenomenon 
might be that the concentration of the substance in the media and matrix 
reached an equilibrium.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. Cumulative drug release of from Thp (A), RSP (B) and LiHCl (C) loaded 
CBs and release profiles of pure substances. 
A 
 
B 
 
C 
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Overall, the dissolution profiles prove that the drug release from the loaded 
CBs is related to the solubility of the APIs in the dissolution media and also 
the loading degree had an effect on the release profile as it can be seen from 
RSP and LiHCl loaded beads. However, the choice of different types of CBs 
did not result in a difference in the release profiles. It can be concluded that 
when the API is freely soluble in the medium, cellulose beads provide a 
controlled release of the substance. Thus, cellulose beads can be utilized for 
controlling the release. 
5.5.2 Anionic cellulose beads (II-III) 
As mentioned in section 5.4.1, drug incorporation into negatively charged CBs 
(anionic) was higher than with the reference beads which were not oxidized 
(see Table 8).  The reason behind this finding is the higher of amount of 
cavities (small meso and micropores) where RaHCl could accumulate in the 
oxidized beads. It is apparent that the significant difference of the released 
amount of drug on the cumulative release profile comes from the drug 
incorporation differences (Figure 13 A). However, regardless of the oxidation 
state of the beads, the drug release levelled off after 2 hours and all types of 
beads released almost an equal percentage of the drug in any given time 
(Figure 13 B). Therefore, it can be concluded that there are no stronger 
interactions between the cationic drug and the anionic surface of the pores 
regarding the drug release rates. 
 
 
 
 
 
 
 
Figure 13. A. Cumulative release profiles B. Release rate (%) of Ranitidine HCl from 
non-oxidized and oxidized CBs at pH 7.4. 
A B 
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To investigate the effect of dissolution media with different pH on the drug 
release, dissolution studies were also performed in sodium phosphate buffer 
media with pH values of 1.2 and 3.6, in addition to 7.4. It was found that the 
swelling of the beads increased with higher oxidization time and higher pH 
of the dissolution media [57]. However, the swelling did not affect the release 
profiles significantly, the drug release profile exhibited a similar pattern 
regardless of the bead type and pH of the dissolution media. The similarity of 
the release profiles indicates that the pores were open and the drug could 
dissolve easily even without swelling and additional opening of the cellulose 
matrix which were reached by higher oxidation. 
5.5.3 Cellulose discs (IV) 
Content studies on CDs have shown that CDs which were loaded in drug 
loading solutions with two specific drug concentrations (80 mg/ml for LiHCl 
and 1 mg/ml for TAA) can provide sufficient content amount within the discs. 
Sink conditions were maintained during the drug release studies since the 
drug content was approx. 4 mg for LiHCl loaded CDs, and 50 µg for TAA 
loaded CDs and dissolution studies were done in 50 ml sodium phosphate 
buffer solutions. 
 
 
 
 
 
 
 
Figure 14. Cumulative drug release rates of LiHCl loaded bilayered buccal patches 
and pure LiHCl in pH 7.4 phosphate buffer (n=3, standard deviations <10% for all 
the cases). 
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Figure 14 shows that the LiHCl release from bilayered patches has a 
characteristic 10-20% initial release in the first 5 minutes and is followed by a 
steady release for the next 4 hours. However, pure LiHCl dissolves very fast 
in the dissolution medium (within 5 minutes). Thus, we can state that 
incorporating LiHCl into CDs with PEG 6000-PEG 400 and obtaining 4 hours 
of release can reduce the frequency of application of LiHCl at the ulcer site 
due to sustained release. 
  
 
 
 
 
 
 
 
 
 
 
Figure 15. Cumulative drug release rates of TAA loaded bilayered buccal patches and 
pure TAA in pH 7.4 phosphate buffer (n=3, standard deviations <10% for all the cases). 
In the case of bilayered patches which were formed with TAA loaded CDs, a 
sustained release of the API from the formulation was also observed, except 
the formulation where loaded CDs did not include any polymers (T1-0:0:100). 
The reason behind the very low and slow release in this specific formulation 
was the entrapment of the API within the matrix due to shrinkage and slow 
diffusion due to the low solubility of the API in the dissolution medium. 
However, Figure 15 shows that the TAA release rates from other formulations 
were similar to each other and approx. 20 µg of the TAA content from all 
formulations were released within 4 hours. A similar effect could be achieved 
with employing CDs compared to the marketed product since the TAA 
content in the marketed product is 25 µg.  
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5.6 Solid state characterization  
5.6.1 FTIR and Raman spectroscopy on empty cellulose beads (II) 
FTIR and Raman spectroscopy studies mainly were conducted by the first 
author of article II. However, it is important to present the findings regarding 
the polymorphic form of empty cellulose beads in the thesis. Therefore, the 
results obtained from spectrophotometric studies on non-ionic and anionic 
CBs which were performed by using FTIR and Raman spectrometers can 
briefly be explained here in this section [56]. The results show that in the 
Raman spectra, vibrations at 1.463 cm-1 and 1266 cm-1 are specific for the 
cellulose II polymorphic form [61]. Thus, it could be concluded that both non-
ionic and anionic CBs were in that specific polymorphic form [61]. In addition, 
the vibrational difference between non-oxidized and oxidized cellulose beads 
are most profound in between the wavenumbers 1400-1600 cm-1 in FTIR, 1400-
1650 cm-1 in the Raman spectrum. Thus, we can state that increasing the 
oxidation temperature resulted in a rise in the linear trend at the vibrations 
which were related to R-COO stretching in these regions. This finding implies 
that an anionic nature (total amount of AGs) can be predicted quantitatively 
by using FTIR/Raman. 
5.6.2 DSC on empty and loaded cellulose beads and discs (III-IV) 
5.6.1.1 Cellulose beads (III) 
DSC analyses were performed after empty and loaded non-ionic and anionic 
CBs were dried at room temperature for at least two days. The results of the 
DSC analysis on empty CBs are presented in Figure 16. The rise on the 
endothermic dehydration peaks at 200-210 °C proves that the hydrophilicity 
of the anionic CBs was increased with oxidation time. Moreover, endothermic 
dehydration for non-ionic (OCB0) was not observed in the region of 200-
210 °C but later at 225 °C. The reason behind this finding was the tighter and 
stronger water bound to the OCB0 internal structure compared to the oxidized 
CBs. 
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Figure 16. Results of DSC analyses on empty non-oxidized (OCB0) and oxidized 
(OCB20-40-60) CBs. 
Figure 17 presents the results of DSC analyses of pure ranitidine HCl and 
loaded non-oxidized and oxidized CBs. In the literature, the melting point of 
RaHCl is described as 134-140 °C for the polymorphic form I, and 144 °C for 
the polymorphic form II [62]. From the graph below, we can see that pure 
RaHCl used in this study has a melting point around 144 °C, thus it can be 
stated that RaHCl was in the polymorphic form II. Also, it is observed that the 
melting is followed by an instant exothermic decomposition. However, an 
endothermic peak which signifies the melting point of RaHCl, could not be 
observed with the drug loaded beads, indicating the amorphous distribution 
of the drug in the cellulose matrix (Figure 17). In addition, the exothermic 
decomposition of RaHCl was delayed 20-50 °C. The reason behind this 
phenomenon could be the slower heat transfer from the cellulose beads to the 
API. 
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Figure 17. Results of DSC analyses of RaHCl, loaded non-oxidized (OCB0) and 
oxidized (OCB20-40-60) CBs. 
In RaHCl loaded beads the endothermic dehydration peaks (around 180 °C) 
were very close to each other. However, these dehydration peaks had 
significant differences in unloaded CBs (Figure 17). This result indicates the 
partial replacement of crystal water embedded in the cellulose matrix with 
RaHCl. In addition, a higher drug loading as function of anionic charges with 
longer oxidation time can be confirmed with increasing exothermic heat flow 
from loaded OCB0 to OCB60. 
5.6.1.2 Cellulose discs (IV) 
As it was mentioned in section 4.2.1-3, the cellulose solutions were dropped 
into the nitric acid solution to form cellulose beads/discs. After the formation 
was completed, the beads/discs were removed from the nitric acid solution 
and washed under tap water for several hours. Washed cellulose beads/discs 
then were immersed into distilled water or ethanol depending on the drug 
loading solution they will be incubated in later. Therefore, DSC studies were 
performed to prove that the washing procedure was efficient enough for the 
removal of nitric acid. Figure 18 compares the DSC analyses of the washed 
and unwashed CDs. 
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Figure 18. Results of DSC analyses of empty washed (1) and unwashed (2) cellulose 
discs. 
In figure 18, the endothermic thermal event before 100 °C indicates the 
evaporation of trapped humidity in the internal structure of the empty 
washed CDs. The absence of any endothermic or exothermic peak proves the 
successful removal of nitric acid or any other residuals such as sodium 
hydroxide or urea, thus we could conclude that the washing technique was 
adequate. On the other hand, unwashed CDs had multiple endothermic peaks 
due to remaining nitric acid in the matrix of the cellulose discs. 
It was essential to determine the solid-state properties of the APIs within the 
CDs. Therefore, pure substances (LiHCl, TAA, PEG 6000, PEG 400), physical 
mixtures, and empty-loaded cellulose discs were examined with DSC (Figure 
19). 
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Figure 19. Results of DSC analyses of (1) LiHCl loaded CDs (L80–15:35:50), (2) 
physical mixture of empty CDs, LiHCl, polymers and (3) pure LiHCl. 
PEG 6000 has a melting point around 55-60 °C [59] and PEG 400 has a melting 
point around 4 °C [63]. Therefore, in figure 19, an endothermic peak assigned 
to the melting of PEG 6000 can be observed in both loaded CDs and physical 
mixtures (1,2). However, due to the low melting point of PEG400, there was 
no observable endothermic change related to PEG 400, both loaded CDs and 
physical mixtures.  
In the literature, the melting point of LiHCl is stated as 70 °C [64]. The 
enthalpy changes due to the melting of LiHCl can be seen in the DSC spectrum 
of pure LiHCl as a sharp endothermic peak (3) and in the physical mixture as 
a small endothermic peak (2). Moreover, no melting point for LiHCl was 
observed in loaded CDs (1). As conclusion we could state that LiHCl is in an 
amorphous state within the matrix of the CDs. However, as it was discussed 
in section 5.3.2, crystalline LiHCl on the surface of the loaded discs was 
observed with FE-SEM analyses. Therefore, it could also be stated that absence 
of an endothermic melting peak in the DSC spectrum of loaded CDs may also 
be a result of dilution rather than conversion to the amorphous form, as the 
endothermic peak assigned to the melting of pure crystalline LiHCl in the 
physical mixture was not very evident, too.  
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Due to the very low amount of TAA in the loaded CDs, it was not possible to 
confirm the solid state of TAA within the CDs by employing DSC. However, 
since the pure crystalline TAA release is similar to the release of TAA from 
loaded CDs (section 5.5.3), it can be assumed that the API is in a crystalline 
state in the CDs in the case of TAA loaded CDs.  
5.6 Other analyses performed on CBs and CDs 
5.6.1 Hyperspectral NIR imaging on empty & loaded CBs (I) 
Dried empty and LiHCl loaded CBs were first cut in half with a razor blade 
and scanned by the hyperspectral NIR imaging equipment. The spectral data 
NIR was visualized by multivariate analysis (Fig. 19 A–D). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19. A contour plot (PCA model) of the original image with an empty cellulose 
bead (left) and a LiHCl loaded CB (right) with chosen pixels of interest from the 
surface of the loaded bead (A) and from the middle of the unloaded bead (C), APCA 
scatter 2D density plot indicating the chosen pixels of interest (coloured in black) (B-
D). The scatter plots show the first and the third principal component (PC), which 
reveal 81.8 and 1.0% of the variation in the spectral data respectively. 
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From the NIR spectral data of the original samples, contour and scatter 2D 
plots can be created by employing principal component analysis (PCA) [65]. 
In Figure 19 A and C in the contour 2D plots, selected pixels of interest can be 
visualized in the 2D scatter density plots as in Figure 19 B and D. These plots 
reveal clusters of pixels with similar NIR spectral properties. In addition, 
selecting pixels in the scatter plot indicate the corresponding pixels in the 
contour 2D image plot. The scatter and contour plots of empty and loaded 
beads indicate that higher drug loading was detected on the outermost of the 
LiHCl loaded beads (Figure 19 A-B). Moreover, when the pixel was chosen 
from the middle of the unloaded beads and spectral date converted to scatter 
plot, there was no drug substance detected (Figure 19 C-D). In addition, it is 
important to state that when analysed further the distinct cluster in the middle 
of the scatter plots corresponds to values in the middle of the loaded bead. 
Similar information was gained for TAA and RSP (data not shown). 
In section 5.5.1, the burst release of LiHCl shown in Figure 12, since NIR 
imaging of loaded LiHCl showed increased drug amount on the outmost 
layer, we could state that burst release can explained by the location of the 
drug on the outer layer. Overall it can be concluded that hyperspectral 
imaging with NIR appears to be a very powerful analytical tool supporting 
the drug distribution behaviour within the beads. 
5.6.2 Mechanical tests on CDs – strength and mucoadhesion (IV) 
Strength and mucoadhesion studies were performed only on CD formulations 
which were used in in-vitro drug release studies. The analyses showed that 
CDs which were prepared by immersing the empty beads into the drug 
loading solutions with 15:35:50 and 0:50:50 (PEG 6000:PEG 400:ethanol, 
w:w:w %) solvent ratios were not breaking, but instead flattened under the 
maximum force of 130 N. All the other formulations were fragile and broke at 
approximately 30 N forces or below. As it was observed and stated in the 
literature, PEG 6000 solidifies within the CDs at room temperature [66], 
therefore these formulations which were loaded in solvents with high PEG 
6000 amounts depicted a fragile morphology. However, it was decided to 
continue studying the formulation which were loaded in a 15:35:50 (PEG 
6000:PEG 400:ethanol, w:w:w %) solvent ratio due to the stronger shrinkage 
preventing abilities of PEG 6000 [58].  
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For mucoadhesion tests, cellulose discs loaded in drug loading solution which 
were prepared by dissolving 80 mg/ml LiHCl and 1 mg/ml TAA in 15:35:50 
(PEG 6000:PEG 400:ethanol) w/w/w solution, and the marketed product Aftab 
were used.  The maximum detachment impulse (N.s) described in section 
4.2.10.2 was determined for each sample and the data is shown in Table 9. 
Table 9. Mucoadhesion test, comparison of positive area under the curve (detachment 
force vs. time, n=3).  
Wetting       
0.1 ml 
Formulation-
Codes 
Positive area 
under peak N.s 
With buffer 
L80-15:35:50 0.37 ±0.09 
T1-15:35:50 0.28 ±0.13 
With saliva 
L80-15:35:50 0.41 ±0.13 
T1-15:35:50 0.26 ±0.10 
No wetting Aftab 0.88 ±0.05 
 
As it can be seen in table 9, the detachment impulse needed to separate the 
CD formulations from the tissues were 30 to 60% of the marketed product 
Aftab. This result indicates that CD formulations are not as mucoadhesive as 
the marketed product. The marketed product, Aftab, includes carbomer and 
polyvinylpyrrolidone (PVP)  as excipients which have better mucoadhesivity 
than PEG 400 and PEG 6000 [67,68]. Thus, different polymers with better oral 
mucoadhesion properties such as carbomer, PVP, poly(acrylic acid), cellulose 
ester derivatives, chitosan, etc. [69,70], should be studied and used in the 
formulation stage in the future. On the other hand, it can be stated that using 
the filtered saliva collected from volunteers or buffer for wetting did not create 
any significant difference on the mucoadhesion. Therefore, buffer solution can 
be used as a substitute for the saliva in future studies. 
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6. Summary and conclusion 
The aim of this thesis was to investigate the potential of the physically and 
chemically modified cellulose for drug delivery purposes. Cellulose was 
dissolved in a water-based environmentally friendly solvent system and then 
the dissolved cellulose was dropped into an acidic medium to form cellulose 
beads and discs (physical modification). Coagulated beads were oxidized to 
obtain functionalised beads (chemical modification).  
Freely and poorly soluble drugs were incorporated into porous non-ionic CBs 
by immersing technique. The results showed that the porosity of the beads 
and the concentration of the drug loading solution were the parameters 
controlling the drug entrapment efficacy. However, the drug release rates 
were only influenced by the solubility of the APIs in the dissolution medium 
since the release was diffusion controlled. When the APIs were freely soluble 
in media, controlled release was achieved by incorporating the drug 
substance into the cellulose bead matrix. Thus, cellulose beads could be 
employed for controlling the release of freely soluble APIs. 
Non-ionic beads were functionalised by using oxidation as a chemical 
modification method. Oxidized (anionic) and unoxidized (non-ionic) beads 
were loaded with a cationic model drug to understand the effect of oxidation 
and the amount of anionic groups in cellulose beads on drug incorporation 
and release. Oxidized beads were able to entrap almost double the amount of 
the model drug compared to non-oxidized beads due to the opening of small 
pores and mesopores with oxidation. However, release profiles were not 
affected by the amount of anionic groups within the beads. Thermal and 
spectroscopic analyses showed that the drug is solidified in amorphous form 
in both bead types. These finding points out that chemically modified beads 
could be utilized in the delivery of poorly soluble drugs. 
In the last stage of this research, a different geometry than beads, namely 
discs, were formed by altering the properties of the precipitation medium. 
Cellulose discs were investigated as drug carrier for oromucosal drug 
delivery. The final formulation consisted of discs, PEG 6000, PEG 400, and EC.  
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Sufficient hardness, desired drug content and in vitro release properties were 
achieved by choosing the correct amount of PEG combination in the 
formulation. A prolonged release of the API for 4 hours in the mucosal area 
could be achieved. However, the mucoadhesive properties were not sufficient 
enough compared to the already marketed product and further studies are 
needed to achieve proper mucoadhesivity.  
In addition to the benefits mentioned above, cellulose beads or discs could 
carry equal amounts of drug content. Thus, acceptable drug content 
uniformity could be achieved due to even volume and weight of the produced 
beads and discs. It could be concluded that due to the easy loading procedure 
with the immersion technique and high content uniformity, cellulose beads 
and discs could be utilized when fast dose adjustment is needed for the final 
formulation. 
As summary, the thesis represents the research performed on regenerated 
non-oxidised cellulose beads, discs (formed by physical modification) and 
oxidized cellulose beads (functionalised by chemical modification) as 
potential drug carriers for different drug delivery systems. This thesis created 
a new understanding for how the novel cellulose beads can be employed to 
control the release of freely soluble and cationic drugs and furthermore how 
cellulose discs can bring new opportunities to oromucosal drug delivery 
systems due to their non-eroding nature which provides a sustained release 
of the API. However, further research is needed to improve their properties 
in order to enrich their attributes as drug carriers. 
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7. Sammanfattning (Summary in Swedish) 
Moderna framsteg inom läkemedelsindustrin har väckt intresse för att 
designa/utforma, modifiera och regenerera polymerer som kan förbättra 
kvaliteten på de slutliga doseringsformerna. Cellulosa, den mest rikliga 
biopolymeren i världen, har grundligt undersökts av forskare under 
årtionden. Egenskaper hos den naturliga cellulosan kan förändras genom 
fysikaliska och kemiska modifieringsmetoder enligt de egenskaper som 
behövs för slutprodukten. Dessa metoder syftar till att bryta 
vätebindningarna mellan cellulosakedjorna eller ersätta en hydroxigrupp 
med en funktionell grupp för att erhålla de önskade egenskaperna. 
Syftet med föreliggande arbetet var att undersöka läkemedelsapplikationer 
av cellulosapärlor och -skivor som framställdes av naturlig cellulosa genom 
en ny/modern, miljövänlig, fysikalisk och kemisk modifieringsteknik.  
Först undersöktes läkemedelsintagning och frisättnings förmågor av porösa 
cellulosapärlor, vilka formulerades genom att upplösa cellulosa i ett 
natriumhydroxid-urea-vatten-lösningsmedelsystem och varefter lösningen 
droppades in i ett surt medium.  
Därefter modifierades cellulosapärlorna kemiskt med oxidation. Dessa 
oxiderade, negativt laddade pärlorna laddades med katjoniska 
läkemedelssubstanser för att undersöka effekten av motsatta laddningar vid 
läkemedelsinfångning och frisättning. Till sist formades den upplösta 
cellulosan till en annan geometrisk form; nämligen skivor, genom att 
modifiera utfällningsmedlets egenskaper för att undersöka deras möjliga 
användning vid läkemedelstillförsel i munhålan. 
Sammanfattningsvis visade resultaten att icke-oxiderade pärlor, oxiderade 
pärlor och skivor kan användas som ett mångsidigt hjälpämne för 
framställning av olika farmaceutiska doseringsformer. En omfattande 
utvärdering av den fulla potentialen hos cellulosapärlor och -skivor behöver 
emellertid ytterligare undersökning. 
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